Skip to main content
Journal for Immunotherapy of Cancer logoLink to Journal for Immunotherapy of Cancer
. 2024 Mar 5;12(3):e008226corr1. doi: 10.1136/jitc-2023-008226corr1

Correction: Targeting oxidative phosphorylation to increase the efficacy of immune-combination therapy in renal cell carcinoma

PMCID: PMC10916080  PMID: 38448039

Tian J, Luo J, Zeng X, et al. Targeting oxidative phosphorylation to increase the efficacy of immune-combination therapy in renal cell carcinoma. J ImmunoTher Cancer 2024;12:e008226. doi: 10.1136/jitc-2023-008226

This article has been corrected since it was first published. Figure 5 contained incorrect images due to a pasting error in the figure assembly process. All images have now been replaced with the correct versions.

Previous figure:

graphic file with name jitc-2023-008226corr1ilf02.jpg

Correct figure:

graphic file with name jitc-2023-008226corr1ilf03.jpg


Articles from Journal for Immunotherapy of Cancer are provided here courtesy of BMJ Publishing Group

RESOURCES